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to overestimation of arterial oxygen saturation by
pulse oximetry in patients with type 2 diabetes
Li Jin Pu1†, Ying Shen1†, Lin Lu1,2, Rui Yan Zhang1, Qi Zhang1 and Wei Feng Shen1,2*Abstract
Background: Non-enzymatic glycation increases hemoglobin-oxygen affinity and reduces oxygen delivery to
tissues by altering the structure and function of hemoglobin.
Objectives: We investigated whether an elevated blood concentration of glycosylated hemoglobin (HbA1c) could
induce falsely high pulse oximeter oxygen saturation (SpO2) in type 2 diabetic patients during mechanical
ventilation or oxygen therapy.
Methods: Arterial oxygen saturation (SaO2) and partial pressure of oxygen (PO2) were determined with
simultaneous monitoring of SpO2 in 261 type 2 diabetic patients during ventilation or oxygen inhalation.
Results: Blood concentration of HbA1c was >7% in 114 patients and ≤ 7% in 147 patients. Both SaO2 (96.2 ± 2.9%,
95% confidence interval [CI] 95.7-96.7% vs. 95.1 ± 2.8%, 95% CI 94.7-95.6%) and SpO2 (98.0 ± 2.6%, 95% CI 97.6-98.5%
vs. 95.3 ± 2.8%, 95% CI 94.9-95.8%) were significantly higher in patients with HbA1c >7% than in those with
HbA1c ≤ 7% (Data are mean ± SD, all p < 0.01), but PO2 did not significantly differ between the two groups.
Bland-Altman analysis demonstrated a significant bias between SpO2 and SaO2 (1.83 ±0.55%, 95% CI 1.73% -1.94%)
and limits of agreement (0.76% and 2.92%) in patients with HbA1c >7%. The differences between SpO2 and SaO2
correlated closely with blood HbA1c levels (Pearson’s r = 0.307, p < 0.01).
Conclusions: Elevated blood HbA1c levels lead to an overestimation of SaO2 by SpO2, suggesting that arterial
blood gas analysis may be needed for type 2 diabetic patients with poor glycemic control during the treatment of
hypoxemia.
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Glycohemoglobin is produced via a non-enzymatic reac-
tion between the free aldehyde group of glucose or other
sugars and the unprotonated form of free amino groups
of hemoglobin [1]. Glycosylated hemoglobin A1c
(HbAlc) is a stable minor hemoglobin variant separated
by charge that is composed primarily but variably of gly-
cohemoglobin. A clinical relationship between blood
concentration of HbAlc and status of glycemic control
has been elucidated [2], and elevated HbAlc levels* Correspondence: rjshenweifeng@yahoo.com.cn
†Equal contributors
1Department of Cardiology, Shanghai Rui Jin Hospital, Shanghai 200025,
People’s Republic of China
2Institute of Cardiovascular Diseases, School of Medicine, Shanghai Jiaotong
University, Shanghai 200025, People’s Republic of China
© 2012 Pu et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the orrepresent increased risk of coronary artery disease and
poor outcome in diabetic patients [3-5]. Previous studies
have shown that glycosylation alters the structure and
function of hemoglobin [6,7] and tends to shift the oxy-
gen dissociation curve to the left, leading to an increase
in hemoglobin-oxygen affinity and a reduction in oxygen
delivery to tissues [6,8,9]. Pulse oximetry is widely used
as a noninvasive tool for continuous monitoring of ar-
tery oxygen saturation (SaO2) [10,11], but pulse oxim-
eter oxygen saturation (SpO2) may overestimate arterial
blood gases-determined SaO2 in acute sickle chest syn-
drome and severe sepsis [12,13]. So far, its accuracy for
titrating fractional inspired oxygen in type 2 diabetic
patients with mechanical ventilation or oxygen therapy
remains unclear. Given that chronic hyperglycemiaThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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products (AGE) in the skin collagen [14], which poses
specific autofluorescence feature, may emit light by
absorbing specific wavelengths light [15], and interfere
with the accuracy of pulse oximetry, it is pertinent to
examine if elevated blood HbAlc concentrations could
result in an overestimation of SaO2 by SpO2 with finger




A total of 261 consecutive type 2 diabetic patients
undergoing oxygen therapy and/or mechanical ventila-
tion from October 2010 to May 2012 in Rui Jin Hospital,
Shanghai Jiaotong University School of Medicine were
included. None had any recorded history of carbon
monoxide exposure. The diagnosis of type 2 diabetes
was made according to the criteria of American Diabetes
Association, including symptoms of diabetes plus casual
plasma glucose concentration beyond 200 mg/dl
(11.1 mmol/l), or an increased fasting (126 mg/dl
[7.0 mmol/l]) or 2-hour postprandial glucose (2-h PG)
level (200 mg/dl [11.1 mmol/l] during an oral glucose
tolerance test) [16]. Patients with type 1 diabetes were
excluded by measurement of C-peptide. For the purpose
of this study, we also excluded patients who were
current cigarette smokers within 3 months or alcohol-
dependent, had renal insufficiency, anemia and fever, or
were treated with vaso-constrictive agents. Poor gly-
cemic control was defined as blood HbAlc level >7%
[17]. The study was approved by the hospital Institu-
tional Review Board (IRB), and written informed consent
was obtained from all participants.
Biochemical assessments
Peripheral venous blood was collected after an over-
night fasting in all patients, and serum levels of glu-
cose, blood urea nitrogen, creatinine, total cholesterol,
low-density lipoprotein-cholesterol (LDL-C), high-
density lipoprotein cholesterol (HDL-C) and triglycer-
ides were measured with standard laboratory techni-
ques on a Hitachi 912 Analyzer (Roche Diagnostics,
Germany). Hemoglobin concentrations were deter-
mined with a model T-890 Coulter (Beckman Coulter
International, Nyon, Switzerland). In order to exclude
individuals with abnormal hemoglobin, electrophoresis
was carried out according to the method of Marengo-
Rowe [18]. Blood HbA1c concentration was assayed
using ion-exchange high performance liquid chroma-
tography with a Bio-Rad Variant Hemoglobin Testing
System (Bio-Rad Laboratories, Hercules, CA, USA).
Levels of 2, 3-diphosphoglycerate (2,3-DPG) in the red
blood cells were assayed within 15 min using enzymaticdetermination at 340 nm with an ultraviolet test kit
from Roche Diagnostics (Roche Diagnostics GmbH,
Mannheim, Germany) according to the manufacturer’s
instructions.
Arterial blood gas analysis
Arterial blood gases were determined during simultaneous
SpO2 monitoring with pulse oximetry. Blood was drawn
anaerobically into a preheparinized 1-mL syringe, and
mixed well before measurement. After removal of all air
bubbles from the syringe, in vivo pH, partial pressure of
carbon dioxide (PCO2), SaO2, partial pressure of oxygen
(PO2) and carboxyhemoglobin were directly measured
using a Cobas b 221 blood gas analyzer (Roche Diagnos-
tics, Germany). All measurements were completed within
5 min of blood sampling. Arterial blood gas analysis and
SpO2 values were one measurement per patient.
Monitoring of pulse oxygen saturation
SpO2 was monitored continuously with a pulse oximetry
(Nellcor NPB 40 MAX, Hayward, California), which
detects oxygen saturation by measuring transdermal light
absorption in the blood flow through a fingertip (DS 100A
finger probe). SpO2 values were recorded only after a con-
sistent reading, with a strong arterial waveform signal and
a pulse reading identical to the patient’s heart rate.
Statistical analysis
Baseline characteristics are expressed as mean and
standard deviation (SD) for continuous variables, and
percentages for categorical ones. Chi-square test was
used to analyze dichotomous variables. Comparisons of
continuous variables between groups were made by the
appropriate Student’s t tests. Correlation between differ-
ence (SpO2 -SaO2) and HbA1c was analyzed using Pear-
son correlation coefficients. Accuracy (SpO2 - SaO2) of
SpO2 was examined by the method of Bland and Altman
analysis [19]. Bias was determined by the mean differ-
ence and 95% confidence intervals (CI) between SpO2
and SaO2, precision was determined by the standard de-
viation of the mean difference, and limits of agreement
(mean difference ±1.96SD) was defined as a proportional
function of distribution for differences between the 2
measurements. Data were analyzed using the Statistical
Packages for Social Sciences (SPSS Version 13.0, Chi-
cago, Ill). A 2-tailed p value < 0.05 was considered statis-
tically significant. Only one measurement per patient for
arterial blood gas and SpO2 was made.
Results
Clinical characteristics
Among overall 261 type 2 diabetic patients, 114 patients
had a HbAlc >7%, and 147 had a HbA1c ≤ 7%. Patients
with HbAlc >7% were older and had higher serum levels
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ides than those with HbA1c ≤ 7%. The two groups did not
differ with respect to occurrence rates of hypertension,
chronic obstructive pulmonary disease, and pulmonary
edema (Table 1).
Arterial blood gas profiles, pulse oximetry, and 2, 3-DPG
Both SaO2 (96.2 ± 2.9%, 95% confidence interval [CI]







Male gender (%) 104(70.7) 78(68.4) 0.685







Pneumonia (%) 40(27.2) 46(40.4) 0.025







Red blood cell (x1012/L) 4.75±0.73 4.91±0.77 0.088
Hemoglobin (g/L) 132±12 134±13 0.199
Body temperature (°C) 37.3±0.1 37.4 ± 0.1 <0.001
Total cholesterol (mmo1/L) 4.06±0.91 4.17±0.95 0.343
HDL-cholesterol (mmo1/L) 1.19±0.26 1.17±0.27 0.545
LDL-cholesterol (mmo1/L) 2.43±0.62 2.41±0.68 0.805
Triglycerides (mmo1/L) 1.72±0.75 1.91± 0.78 0.047
Fasting Glucose (mmo1/L) 5.9±1.8 9.4±2.1 <0.001
2-h postprandial glucose
(mmo1/L)
9.2±4.1 13.9± 4.5 <0.001




Creatinine (μmo1/L) 87±16 91±18 0.59
Medical treatments




Statins* (%) 121(82.3) 97(85.1) 0.549
Metformin (%) 52(35.4) 45(39.5) 0.497
Sulphonylureas (%) 56(38.1) 37(32.5) 0.345
Alpha-glucosidase (%) 54(36.7) 46(40.3) 0.551
PPAR-gamma agonist (%) 23(15.6) 15(13.2) 0.572
Data are mean ± SD or number (%).
Abbreviation: HbA1c, Glycosylated hemoglobin A1c; HDL, High-density
lipoprotein.
LDL, low-density lipoprotein; ACEI, andgiotensin-converting enzyme inhibitor.
ARB, angiotensin II receptor blocker.
*Statins: mainly simvastatin, pravastatin and atorvastatin.(98.0 ± 2.6%, 95% CI 97.6-98.5% vs. 95.3 ± 2.8%, 95% CI
94.9-95.8%) were significantly higher in patients with
HbA1c >7% than in those with HbA1c ≤ 7% (Data are
mean ± SD, all p < 0.01), but PO2 did not significantly
differ between the two groups.
Levels of 2, 3-DPG in the red blood cells and PCO2
were slightly elevated in patients with HbA1c >7%, but
did not reach statistical significance levels (p >0.05).
Body temperature, pH, and carboxyhemoglobin were
similar in the two groups (Table 2).
The difference between SpO2 and SaO2 correlated
closely with blood HbA1c levels (Pearson’s r = 0.307, p <
0.01) (Figure 1).
Arterial oxyhemoglobin sigmoid curves
The sigmoid fitted curve for patients with HbA1c >7%
shifted to the left compared with that with HbA1c ≤ 7%.
The mean difference of SaO2 between diabetic patients
with HbA1c >7% and those with HbA1c ≤ 7% was 1.1%
(Figure 2).
Bland-Altman analysis
The simultaneous readings of SaO2 and SpO2 were ana-
lyzed to determine the bias and limits of agreement.
Bland-Altman analysis indicated that the bias (mean dif-
ference of SpO2 minus SaO2) between the two methods
was 1.83 ±0.55% (95% CI1.73% -1.94%) and limits of
agreement were 0.76% and 2.92% in patients with
HbA1c >7% (Figure 3). Overall, there was a significant
bias between pulse oximetry and arterial blood gases in
patients with HbA1c >7%.
Discussion
The present study is the first to demonstrate that despite
similar levels of red blood cell 2, 3-DPG, PO2, PCO2, pH
and body temperature, type 2 diabetic patients with
HbA1c > 7% had higher SaO2 (the mean difference wasTable 2 Arterial blood gas analysis, 2,3-DPG level and






2, 3-DPG(μmo1/gHb) 13.9±1.7 14.2±1.7 0.09
pH 7.37±0.05 7.39±0.05 0.01
PCO2 (Kpa) 5.48±0.73 5.53±0.65 0.565
Carboxyhemoglobin (%) 1.08±0.81 1.09±0.78 0.92
PO2 (Kpa) 10.0±1.9 10.0±2.2 0.843
SaO2 (%) 95.1±2.8 96.2±2.9 0.002
SpO2 (%) 95.3±2.8 98.0±2.6 0.001
Data are mean ± SD.
Abbreviation: 2,3-DPG, 2, 3-diphosphosglycerate.
PCO2, partial pressure of carbon dioxide.
PO2, partial pressure of oxygen; SaO2, arterial oxygen saturation.
SpO2, pulse oximeter oxygen saturation.
Figure 1 Correlation of the difference between SpO2 and SaO2 with blood HbA1c levels in patients with poor glycemic control.
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HbA1c ≤ 7%, suggesting that elevated blood HbAlc levels
led to an overestimation of SaO2 by pulse oximetry.
Hypoxemia denotes a condition that is characterized
by low oxygen content or percent saturation of
hemoglobin with oxygen [13]. Arterial blood gases have
been traditionally used to assess the status of oxygen-
ation and to adjust fractional inspired oxygen in patients
receiving mechanical ventilation or oxygen therapy [20].
Currently, noninvasive continuous monitoring of SaO2
with SpO2 has become the standard care for patients
with critical conditions [13,21], to decrease the likeli-
hood of hypoxemia [22-25] and to wean mechanical
ventilation [10,11,26]. In the present study, when com-
parisons were performed at identical PO2, SaO2 was
higher in type 2 diabetic patients with HbA1c > 7%,
which is likely due to an increased hemoglobin-oxygen
affinity. Our results are in line with previous findings
that higher blood concentrations of HbA1c significantly
reduce oxygen dissociation velocity [27]. Although the
exact mechanism remains not fully understood, it may
be, at least partly, explained by glycation of multiple ß-Figure 2 Arterial oxyhemoglobin sigmoid curves (PO2, partial pressurchain sites of hemoglobin A molecule, accompanied by
increasing -chain glycation at high glycohemoglobin
concentrations [28,29].
The major finding of this study is that in type 2 dia-
betic patients with poor glycemic control, pulse oximetry
overestimated arterial blood gases-determined SaO2 by a
mean of 2.7% when compared with those with HbA1c ≤
7%. Previous studies showed that older women have
higher HbA1c than men, even after controlling for body
mass index [30], and accumulation of AGE in human
skin collagen is age-dependent [31]. However, both gen-
der distribution and age did not significantly differ be-
tween the two groups in the present study, suggesting
that the difference between SpO2 and SaO2 may be
mainly related to HbA1c levels as higher HbA1c levels
were associated with great differences (Pearson’s r =
0.307, p < 0.01).
Our findings may be of important clinical relevance.
First, falsely high SpO2 could cause under-diagnosis of
hypoxemia in type 2 diabetic patients. Second, because a
greater SpO2 was required to achieve the same arterial
blood gases-determined PO2 for diabetic patients withe of oxygen; SaO2, arterial oxygen saturation).
Figure 3 Bland-Altman plots for bias and limits of agreement in patients with poor glycemic control.
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should be taken in adjusting oxygen supply during
mechanical ventilation or oxygen therapy. The reason
for a higher SpO2 than SaO2 may be partly explained by
an extensive accumulation of AGE in the skin collagen
in patients with poor glycemic control [14], interfering
with transdermal absorption of the specific wavelength
light by hemoglobin with finger probes [12,32]. These
observations support a notion that the causes of high
bias does include skin effect [33,34], and when SaO2
needs to be determined with a high degree of accuracy,
arterial blood gases are recommended in type 2 diabetic
patients with poor glycemic control.
Limitations
Due to relatively small sample size, potential for selec-
tion bias may raise some concerns on the statistical pre-
cision of the estimates. A large-scale study is warranted
to confirm our findings. The other major limitation is
that most of the data are at high SaO2 because of a spe-
cially selected study population as all patients were re-
ceiving mechanical ventilation and/or oxygen therapy.
The oxyhemoglobin dissociation curves could actually
be fitted with non-linear regression, and a partial pres-
sure of oxygen in blood associated to a hemoglobin oxy-
gen saturation of 50% (P50) could also be calculated
[35]. Most oximetry testing intentionally gathers data
below 90% by performing desaturation experiments in
volunteers. Gather multiple data points on volunteers in-
crease the data set substantially, and allow one to test
over a wide range of SaO2, and control for other effects.
By creating a gas pocket with CO2 and O2/N2 mixtures,
one can create a much more detailed oxyhemoglobin
dissociation curve. The US FDA requires testing
balanced by gender and ethnicity. Repeated measures
statistics would then be necessary, and P50 is not deter-
mined quite as precisely unless the sample is near a
SaO2 of 50%. Certainly, it remains unclear whether the
issue with diabetic patients would be safe given thepossibility of cardiovascular disease, although younger
subjects could be reasonable.
Conclusions
Elevated blood HbA1c concentrations lead to an over-
estimation of SaO2 by SpO2, suggesting that arterial
blood gas analysis may be needed for type 2 diabetic
patients with poor glycemic control during the treat-
ment of hypoxemia.
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